FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W85290112> ?p ?o ?g. }

• W85290112 endingPage "5" @default.
• W85290112 startingPage "111" @default.
• W85290112 abstract "Quantification of the magnitude of thrombotic risk associated with malignancy and with anti-cancer therapy is indispensable to use anticoagulant drugs which selectively interfere with haemostatic mechanisms protecting patients from venous thromboembolism (VTE) and probably from tumor progression. However, none of activation coagulation markers has any predictive value for the occurrence of the thrombotic events in one individual patient. Current clotting methods can't reveal the overall dynamic clot formation; in contrast thromboelastographic methods specifically assess overall coagulation kinetics and its strength in whole blood.Objective of study was to evaluate if the activation of coagulation as eventually revealed by ROTEM thromboelastometry could assess an hypercoagulable state in surgical neoplastic patients.Fifty consecutive patients with carcinoma of the digestive tract in preoperative period (23 M, 27 F aging 61.5 (45-79 years) and 147 healthy subjects (71 M, 76 F) were studied. A recent thromboelastometric method based on thrombelastography after Hartert was employed. Measurements were performed on ROTEM Coagulation Analyzer. The continuous coagulation data from 50 min course were transformed into dynamic velocity profiles of WB clot formation.Standard parameters (CT, CFT, MCF) of cancer patients were similar to controls. CT (in cancer patients): females 50 s (38.3-58.7), males 50 s (42-71.2) vs 51 s (42-59), p = 0.1210 / 53 s (42-74.8), p = 0.1975 (in controls). CFT (in cancer patients): females 72 s (32- 92.4), males 80 s (50.2- 128.7) vs 78 s (62-100), p = 0.0128 / 80 s (59-124.4), p = 0.9384 (in controls). MCF (in cancer patients): females 70 mm (59.9-82.5), males 63 mm (56-73.7) vs 69 mm (59-95.8), p = 0.9911 / 69 mm (53.6-90), p = 0.0135 (in controls). Females showed a higher MaxVel when compared to males. The MaxVel was increased in cancer patients: females 19 mm /100 s (14.3-49.5) males 18 mm / 100 s (11-27) vs 15 mm 100 s (11.8-22), p < 0.001 / 13 mm / 100 s (10-21.8), p < 0.001 in controls. The t-MaxVel was shortened in cancer patients: females 65s (48.6-112.8), males 81s (50.1-135.9) vs 115s (56.8-166), p < 0.001 / 115 s (59.8-180.8), p = 0.0002 in controls. The AUC was increased in cancer patients: females 6451 mm 100(5511-8148), males 5984 mm 100 (5119-6899) vs 5778 mm 100 (4998-6655), p < 0.001 / 5662 mm 100 (4704-6385), p = 0.0105.Unlike other assays measuring variations in a single component during coagulation, the thrombelastographic method records a profile of real-time continuous WB clot formation, and may provide extensive informations on haemostasis in neoplastic patients before surgery." @default.
• W85290112 created "2016-06-24" @default.
• W85290112 creator A5003503228 @default.
• W85290112 creator A5005724057 @default.
• W85290112 creator A5014273755 @default.
• W85290112 creator A5020660579 @default.
• W85290112 creator A5038323557 @default.
• W85290112 creator A5039120727 @default.
• W85290112 creator A5039953259 @default.
• W85290112 creator A5042758138 @default.
• W85290112 creator A5053112027 @default.
• W85290112 creator A5073666123 @default.
• W85290112 creator A5080190829 @default.
• W85290112 creator A5084584130 @default.
• W85290112 creator A5084728078 @default.
• W85290112 creator A5090889775 @default.
• W85290112 date "2007-06-01" @default.
• W85290112 modified "2023-09-27" @default.
• W85290112 title "Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer." @default.
• W85290112 cites W1991130709 @default.
• W85290112 cites W1992416676 @default.
• W85290112 cites W2007086823 @default.
• W85290112 cites W2009225170 @default.
• W85290112 cites W2015263152 @default.
• W85290112 cites W2022932023 @default.
• W85290112 cites W2056425903 @default.
• W85290112 cites W2067120192 @default.
• W85290112 cites W2071501692 @default.
• W85290112 cites W2116551318 @default.
• W85290112 cites W2134477676 @default.
• W85290112 cites W2141737393 @default.
• W85290112 cites W2149155137 @default.
• W85290112 cites W2169375165 @default.
• W85290112 cites W2273671484 @default.
• W85290112 cites W2438040745 @default.
• W85290112 cites W2441007878 @default.
• W85290112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17704742" @default.
• W85290112 hasPublicationYear "2007" @default.
• W85290112 type Work @default.
• W85290112 sameAs 85290112 @default.
• W85290112 citedByCount "9" @default.
• W85290112 countsByYear W852901122015 @default.
• W85290112 countsByYear W852901122017 @default.
• W85290112 countsByYear W852901122018 @default.
• W85290112 countsByYear W852901122019 @default.
• W85290112 crossrefType "journal-article" @default.
• W85290112 hasAuthorship W85290112A5003503228 @default.
• W85290112 hasAuthorship W85290112A5005724057 @default.
• W85290112 hasAuthorship W85290112A5014273755 @default.
• W85290112 hasAuthorship W85290112A5020660579 @default.
• W85290112 hasAuthorship W85290112A5038323557 @default.
• W85290112 hasAuthorship W85290112A5039120727 @default.
• W85290112 hasAuthorship W85290112A5039953259 @default.
• W85290112 hasAuthorship W85290112A5042758138 @default.
• W85290112 hasAuthorship W85290112A5053112027 @default.
• W85290112 hasAuthorship W85290112A5073666123 @default.
• W85290112 hasAuthorship W85290112A5080190829 @default.
• W85290112 hasAuthorship W85290112A5084584130 @default.
• W85290112 hasAuthorship W85290112A5084728078 @default.
• W85290112 hasAuthorship W85290112A5090889775 @default.
• W85290112 hasConcept C121608353 @default.
• W85290112 hasConcept C126322002 @default.
• W85290112 hasConcept C26809991 @default.
• W85290112 hasConcept C2777664302 @default.
• W85290112 hasConcept C2778382381 @default.
• W85290112 hasConcept C2779036427 @default.
• W85290112 hasConcept C2779399171 @default.
• W85290112 hasConcept C2780868729 @default.
• W85290112 hasConcept C2910686401 @default.
• W85290112 hasConcept C71924100 @default.
• W85290112 hasConcept C90924648 @default.
• W85290112 hasConceptScore W85290112C121608353 @default.
• W85290112 hasConceptScore W85290112C126322002 @default.
• W85290112 hasConceptScore W85290112C26809991 @default.
• W85290112 hasConceptScore W85290112C2777664302 @default.
• W85290112 hasConceptScore W85290112C2778382381 @default.
• W85290112 hasConceptScore W85290112C2779036427 @default.
• W85290112 hasConceptScore W85290112C2779399171 @default.
• W85290112 hasConceptScore W85290112C2780868729 @default.
• W85290112 hasConceptScore W85290112C2910686401 @default.
• W85290112 hasConceptScore W85290112C71924100 @default.
• W85290112 hasConceptScore W85290112C90924648 @default.
• W85290112 hasIssue "2" @default.
• W85290112 hasLocation W852901121 @default.
• W85290112 hasOpenAccess W85290112 @default.
• W85290112 hasPrimaryLocation W852901121 @default.
• W85290112 hasRelatedWork W2096170942 @default.
• W85290112 hasRelatedWork W2106242762 @default.
• W85290112 hasRelatedWork W2416359461 @default.
• W85290112 hasRelatedWork W2531442752 @default.
• W85290112 hasRelatedWork W2803617465 @default.
• W85290112 hasRelatedWork W2805539979 @default.
• W85290112 hasRelatedWork W2936470068 @default.
• W85290112 hasRelatedWork W4210614043 @default.
• W85290112 hasRelatedWork W577122811 @default.
• W85290112 hasRelatedWork W2146362299 @default.
• W85290112 hasVolume "29" @default.
• W85290112 isParatext "false" @default.

• next